Qin, S., Kruger, E., Tan, S. C., Cheng, S., Wang, N., & Liang, J. (2018). Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China. Cost Eff Resour Alloc.
শিকাগো স্টাইলে সাইটেশনQin, Shukui, Eliza Kruger, Seng Chuen Tan, Shuqun Cheng, Nanya Wang, এবং Jun Liang. "Cost-effectiveness Analysis of FOLFOX4 and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma in China." Cost Eff Resour Alloc 2018.
এমএলএ সাইটেশনQin, Shukui, et al. "Cost-effectiveness Analysis of FOLFOX4 and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma in China." Cost Eff Resour Alloc 2018.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.